Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival
SiewertIIEAC
SiewertIIEAC
Sponsor study identifier
observational
154
1 country
2
Study Start
January 1, 2007
Actual (reported)Primary Completion
June 30, 2017
Actual (reported)Study Completion
June 30, 2017
Actual (reported)In Siewert type II adenocarcinoma, the relationship between adenocarcinoma sub types and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases, were investigated.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2007
Actual (reported)June 30, 2017
Actual (reported)June 30, 2017
Actual (reported)January 23, 2018
Actual (reported)January 30, 2018
Actual (reported)Survival
5 year survival between intestinal and diffuse types (Lauren's classification) of Siewert type II adenocarcinoma after primary surgery,
5 years
Frequency of gastric greater curvature lymph nodes metastases in Siewert II adenocarcinoma
5 years
The esophagus was resected at the arch level of the azygos vein, a frozen section of the resection margin was routinely performed to achieve a proximal clean resection margin. The surgical specimen was comprehensive of distal esophagus, stomach and omentum. Digestive tract continuity was established with Roux-en-Y esophagojejunostomy. Lymphadenectomy was extended to the thoracic stations R 2-4, 7-8-9, and L 4, numbered according to the Mountain's classification \[39\] (Suppl. File 2 Figure A) and to the abdominal stations 1-12, numbered according to the Japanese Research Society for Gastric Cancer (JRSGC) 1998 classification.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
One hundred fifty four Siewert type II cases were enrolled: 124 men (80.5%), 30 women (19.5%), median age 65.5 (interquartile range 58-71); Intestinal type 91 (59%) and Diffuse type 63 (41%).
Department of Medical and Surgical Sciences University of Bologna
Bologna, Bo, 40138, Italy
Sandro Mattioli - Alma Mater Studiorum-University
Bologna, BO, 40138, Italy
Surgical specimen
Sandro Mattioli - Alma M Studiorum-University, MD
Department of Medical and Surgical Sciences
154 participants (actual enrollment reported by the registry).
First Submitted
January 23, 2018
First Posted
January 30, 2018
Study Start
January 1, 2007
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
June 30, 2017
Actual (reported)Study Completion
June 30, 2017
Actual (reported)Last Updated
January 30, 2018
Record last verified: 2018-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: